StockData
Precigen, Inc. logo

Precigen, Inc. (PGEN) stock

PGENNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 2/30
$4.21+0.05 (+1.20%)

Close on Nov 20, 2026Market cap $1.51BP/E –Yield –

Precigen gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

Precigen's gross profit for the twelve months ending Jun 30, 2018 was $168.17M, up 0.3% year over year. For fiscal 2017 it was $186.20M, up 21.5% from the year before. The highest annual figure on record is $186.20M in fiscal 2017.

Annual gross profit

PeriodPeriod endValueChange
FY2017Dec 31, 2017$186.20M+21.5%
FY2016Dec 31, 2016$153.22M+15.3%
FY2015Dec 31, 2015$132.86M+118.2%
FY2014Dec 31, 2014$60.90M+156.5%
FY2013Dec 31, 2013$23.74M+72.3%
FY2012Dec 31, 2012$13.77M–

Quarterly gross profit

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2018Jun 30, 2018$32.13M-29.5%
Q1 FY2018Mar 31, 2018$28.63M-35.7%
Q4 FY2017Dec 31, 2017$69.39M+83.7%
Q3 FY2017Sep 30, 2017$38.02M-4.6%
Q2 FY2017Jun 30, 2017$45.57M–
Q1 FY2017Mar 31, 2017$44.50M–
Q4 FY2016Dec 31, 2016$37.76M–
Q3 FY2016Sep 30, 2016$39.83M–

More Precigen figures

See a number that looks wrong?